News
Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...
Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...
In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...
Thirty-nine percent of millennials and 35% of Gen Z say access to weight loss drugs would improve their job satisfaction or ...
The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.
From gastric band surgery to Ozempic, the 72-year-old has been candid about her diet and weight loss techniques.
As weight loss jabs like Ozempic become ever more popular, doctors are growing increasingly concerned about their gnarly side effects.
Most policies still exclude weight-loss medications under general exclusions unless they are part of the treatment of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results